With over 43 years of pharmaceutical industry experience, Tim is a founding officer and current Chairman/COO of Neva Analytics LLC. (Neva). This experience extends directly across several pharma organizations ranging from large global operations (American Home Products/Wyeth-Ayerst) and mid-size development programs (Amylin Pharmaceuticals), to early-stage/startup companies (FeRx Incorporated and RMC Pharmaceutical Solutions, Inc.) – as well as simultaneously serving in multiple contract senior management roles for global organizations since 2005 until his retirement as Principal Consultant at RMC in 2023. This uniquely diverse background, includes direct experience overseeing the entire GxP spectrum (i.e., GMP, GLP, GCP, GDP and GVP) of activities that support pre-clinical/clinical research, CMC/product development and commercialization of regulated drug and device products on a global basis. This background is not only an asset to Neva’s corporate development, but it allows Tim to serve as a key internal quality and operational advisor to the Neva operations team.